Christina Poh, MD

Physician
Seattle Cancer Care Alliance
Assistant Professor, Division of Medical Oncology
University of Washington School of Medicine
Specialty:
Medical Oncology
“As doctors, we are trained to give advice, answer questions and offer treatment, yet sometimes that’s not all patients need. Sometimes they need a friend — someone to listen, someone to remind them that cancer doesn’t define who they are.”
— Dr. Poh
Why do you practice oncology?

Oncology allows me to spend one-on-one time with patients while incorporating innovative research into what I’m doing each day. I have the privilege of standing by my patient's side, being their advocate as they navigate a difficult diagnosis. At the same time, I have the opportunity to explore my research interests and use these finding to improve care firsthand. There aren’t many areas of medicine where those two facets are so closely intertwined. I chose to specialize in treating lymphoma because I was inspired by the strides my mentors were making in this field. Lymphoma is a disease that in many cases can be cured, and there is a lot of satisfaction in being able to work toward that goal with my patients. 

Poh-new-secondary.jpg
Tell us about an interaction with a patient that had a significant impact on you.

During my medical training, I met a patient with leukemia who was admitted to the hospital. He lived several hours away, and his family didn’t have the means to visit him. Over the course of a month, I saw him every day; we bonded as he went through treatment. At one point, he took a turn for the worse and ended up in the intensive care unit (ICU). Although he was under the care of a different team, I would still try to drop by and see him a few days a week. During those visits, he asked me if I could just sit, hold his hand and talk about anything not related to his cancer. So that’s what we did, and it had a profound effect on us both. As doctors, we are trained to give advice, answer questions and offer treatment, yet sometimes that’s not all patients need. Sometimes they need a friend — someone to listen, someone to remind them that cancer doesn’t define who they are. My patient in the ICU taught me that, and it’s made me a better doctor.

Provider background

Specialty: Medical Oncology

Lymphomas, chronic lymphocytic leukemia

I am a hematologist-oncologist who specializes in the treatment of lymphomas and chronic lymphocytic leukemia (CLL). My approach to care is based on candid, clear communication and teamwork. In addition to providing care, I am also an active clinical researcher. My research interests include testing new drug combinations to improve effectiveness and decrease toxicity. I also investigate risk factors that lead to lymphoma and complications that survivors of lymphoma can experience, such as secondary cancers. My aim is to improve their long-term quality of life.   

 

 

 

Diseases treated

Education, experience and certifications
Undergraduate Degree
University of Rochester
Medical Degree
Loma Linda University School of Medicine
Residency
Loma Linda University Health, Internal Medicine
Fellowship
University of California, Davis, Hematology-Oncology
Board Certification
Hematology, 2020; Oncology, 2020; Internal Medicine, 2017, American Board of Internal Medicine
Languages
English
Thai

Research

Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
NCT04680052
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. (InMIND)
Complete title
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to Rituximab Versus Lenalidomide in Addition to Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma Grade 1 to 3a or R/R Marginal Zone Lymphoma

Publications

Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Team coordinator (TC)
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.

Insurance

SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.